Tag Archives: middleman

There is a vast public literature–academic, legal, and popular–that claims Bayh-Dole is a wild success. That literature claims that compliance with Bayh-Dole requires commercialization, and that it is by commercialization that public benefit from federal research comes about. That argument reduces … Continue reading →